Bristol Myers Squibb SG&A Expenses 2010-2024 | BMY

Bristol Myers Squibb sg&a expenses for the twelve months ending June 30, 2024 were $8.371B, a 6.07% increase year-over-year.

  • Bristol Myers Squibb annual sg&a expenses for 2023 were $7.772B, a 0.54% decline from 2022.
  • Bristol Myers Squibb annual sg&a expenses for 2022 were $7.814B, a 1.61% increase from 2021.
  • Bristol Myers Squibb annual sg&a expenses for 2021 were $7.69B, a 0.38% increase from 2020.

Bristol Myers Squibb SG&A Expenses 2010-2024 | BMY

  • Bristol Myers Squibb annual sg&a expenses for 2023 were $7.772B, a 0.54% decline from 2022.
  • Bristol Myers Squibb annual sg&a expenses for 2022 were $7.814B, a 1.61% increase from 2021.
  • Bristol Myers Squibb annual sg&a expenses for 2021 were $7.69B, a 0.38% increase from 2020.